Number of Matches 400 Showing matches 1 - 10 Sort By: Relevance | Date
1 FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir (Harvoni or Sovaldi) in combination with another direct acting antiviral drug Full Text FDA What's New: Drugs, March 26, 2015
2 Risk factors associated with overweight cluster already in children University of Eastern Finland News, March 26, 2015
3 Exciting data presented at the 4th Gut Microbiota For Health Summit American Gastroenterological Association News, March 23, 2015
4 Rebooting cell programming can reverse liver failure, says Children's Hospital/Pitt study UPMC, March 19, 2015
5 FDA approves Cholbam to treat rare bile acid synthesis disorders Full Text FDA Press Announcements, March 18, 2015
6 Study details microRNA’s role as a double agent during Hep C infection Rockefeller University News, March 16, 2015
7 Study: How microbiome affects liver's response to medication UW Medicine, March 11, 2015
8 Newly discovered actions for gut hormone GLP-1 has implications for bariatric surgery and immune disorders Lunenfeld-Tanenbaum Research Institute News, March 11, 2015
9 Hispanics develop alcoholic liver disease at younger ages than Caucasians or African Americans UC Davis Health System, March 10, 2015
10 NIH-led study to assess community-based hepatitis C treatment in Washington, DC Full Text NIH News, March 9, 2015
What do you want to see on liver?
2015 © M3 USA. ALL Rights Reserved.